Active surveillance means monitoring a low-risk prostate cancer closely rather than treating it straight away. It involves regular PSA tests, examinations, scans and sometimes repeat biopsies. If the cancer shows signs of changing, treatment can begin. It is not the same as ignoring the cancer.

Why would a doctor suggest not treating cancer?

Because some prostate cancers grow so slowly that they will never cause harm, and treatment carries real costs. Surgery and radiation can affect urinary control and sexual function. Surveillance avoids those costs for as long as it is safe to do so.

This is a recognised treatment pathway in national guidelines. It is not a cheaper alternative and it is not a way of avoiding work.

Who is suitable?

Generally men with Grade Group 1 disease, a low PSA, cancer still confined to the prostate, and limited involvement on biopsy. Some men with favourable Grade Group 2 may also be candidates. Read how grade groups work.

What does it actually involve?

This is an active programme with appointments, not a decision to do nothing.

When does it change to treatment?

If the grade rises on a repeat biopsy, if the scan changes, or if your PSA starts behaving differently.

And if you decide you no longer want to wait. That is a legitimate reason. Living with an untreated cancer is difficult for some men regardless of what the statistics say, and that matters.

The honest trade-off

Surveillance avoids or delays side effects. The cost is ongoing tests and the knowledge that the cancer is still there.

Treatment removes that uncertainty. The cost is side effects that some men would never have needed.

Neither is obviously the right answer, and a surgeon who tells you otherwise without seeing your records is guessing.

Dr. Samadi reviews outside pathology, scans and reports as part of a second opinion.

Request a second opinion review

Common questions

Is active surveillance safe?

For carefully selected men with low-risk prostate cancer, long-term studies show outcomes comparable to immediate treatment. Safety depends on the cancer genuinely being low-risk and on the monitoring being followed properly. It is not suitable for higher-grade cancers.

How often will I be tested on active surveillance?

Schedules vary between doctors. Most involve PSA tests every few months, a physical examination, periodic MRI scans and repeat biopsies at set intervals. Your own schedule depends on your grade, your PSA and how stable your results have been.

Can I switch to treatment later?

Yes. That is the point of surveillance. If monitoring shows the cancer is changing, or if you simply decide you no longer want to wait, treatment options remain open. Most men who switch do so while the cancer is still curable.

What is the difference between active surveillance and watchful waiting?

Active surveillance means regular testing with the intention of treating if anything changes. Watchful waiting is less intensive and is usually chosen for men whose age or health means treatment would not benefit them, with any treatment aimed at symptoms rather than cure.

Does active surveillance mean my cancer is not serious?

It means your cancer currently looks slow-growing and unlikely to spread soon. It is still cancer and still needs monitoring. The recommendation reflects the behaviour of your particular cancer, not a judgment that it does not matter.